Weekly methotrexate: harmful to exposed embryos.
D000014:Abnormalities, Drug-Induced / Q000175:diagnosis / Q000209:etiology*; D000022:Abortion, Spontaneous / Q000139:chemically induced* / Q000175:diagnosis; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D004334:Drug Administration Schedule; D004622:Embryo, Mammalian / Q000187:drug effects; D005260:Female; D005493:Folic Acid Antagonists / Q000008:administration & dosage* / Q000009:adverse effects*; D005865:Gestational Age; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D008727:Methotrexate / Q000008:administration & dosage* / Q000009:adverse effects*; D061214:Patient Safety; D011247:Pregnancy; D018570:Risk Assessment; D012307:Risk Factors
D000970:Antineoplastic Agents; D005493:Folic Acid Antagonists; D007166:Immunosuppressive Agents; D008727:Methotrexate